机构:[1]Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Key Laboratory of Molecular Cardiovascular Science of the Ministry of Education, Center for Non-coding RNA Medicine, Peking University Health Science Center, Beijing 100191, China[2]Hypertension Center, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Beijing 100037, China[3]Beijing Key Laboratory of Diabetes Research and Care, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China首都医科大学附属北京同仁医院首都医科大学附属同仁医院[4]Department of Gastroenterology, Peking University People’s Hospital, Beijing 100044, China[5]Department of Central Laboratory & Institute of Clinical Molecular Biology, Peking University People’s Hospital, Beijing 100044, China
FAM3A is a recently identified mitochondrial protein that stimulates pancreatic-duodenal homeobox 1 (PDX1) and insulin expressions by promoting ATP release in islet beta cells. In this study, the role of intracellular ATP in FAM3A-induced PDX1 expression in pancreatic beta cells was further examined. Acute FAM3A inhibition using siRNA transfection in mouse pancreatic islets significantly reduced PDX1 expression, impaired insulin secretion, and caused glucose intolerance in normal mice. In vitro, FAM3A overexpression elevated both intracellular and extracellular ATP contents and promoted PDX1 expression and insulin secretion. FAM3A-induced increase in cellular calcium (Ca2+) levels, PDX1 expression, and insulin secretion, while these were significantly repressed by inhibitors of P2 receptors or the L-type Ca2+ channels. FAM3A-induced PDX1 expression was abolished by a calmodulin inhibitor. Likewise, FAM3A-induced beta-cell proliferation was also inhibited by a P2 receptor inhibitor and an L-type Ca2+ channels inhibitor. Both intracellular and extracellular ATP contributed to FAM3A-induced PDX1 expression, insulin secretion, and proliferation of pancreatic beta cells.
基金:
Beijing Natural Science FoundationBeijing Natural Science Foundation [7212123/7171006/7204320]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [82070844/81670787/81670748/81471035/818 70551/81800367/81900492]; National Key Research Program of China [2016YFC0903000/2017YFC0909600]; State Key Laboratory of Cardiovascular Disease Grant [2018fk-02]
第一作者机构:[1]Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Key Laboratory of Molecular Cardiovascular Science of the Ministry of Education, Center for Non-coding RNA Medicine, Peking University Health Science Center, Beijing 100191, China
通讯作者:
通讯机构:[5]Department of Central Laboratory & Institute of Clinical Molecular Biology, Peking University People’s Hospital, Beijing 100044, China[*1]Department of Central Laboratory & Institute of Clinical Molecular Biology, Peking University People’s Hospital 100044 Beijing
推荐引用方式(GB/T 7714):
Yan Han,Chen Zhenzhen,Zhang Haizeng,et al.Intracellular ATP Signaling Contributes to FAM3A-Induced PDX1 Upregulation in Pancreatic Beta Cells[J].EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES.2022,130(08):498-508.doi:10.1055/a-1608-0607.
APA:
Yan, Han,Chen, Zhenzhen,Zhang, Haizeng,Yang, Weili,Liu, Xiangyang...&Yang, Jichun.(2022).Intracellular ATP Signaling Contributes to FAM3A-Induced PDX1 Upregulation in Pancreatic Beta Cells.EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES,130,(08)
MLA:
Yan, Han,et al."Intracellular ATP Signaling Contributes to FAM3A-Induced PDX1 Upregulation in Pancreatic Beta Cells".EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES 130..08(2022):498-508